Therapeutic effectiveness and adverse drug reactions of mirabegron versus solifenacin in the treatment of overactive bladder syndrome

Introduction: Overactive bladder (OAB) syndrome is a chronic disease characterized by urinary urgency with or without urge incontinence, frequency, and nocturia and antimuscarinic drugs such as solifenacin have been the mainstay of treatment. Mirabegron a beta 3 adrenoreceptor agonist has recently g...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Megha O. Raj, Jinish Jose, Fredrick Paul, Syam Sreedharan, Nithya Uthaman
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wolters Kluwer Medknow Publications 2024-08-01
Serie:	Perspectives in Clinical Research
Soggetti:	antimuscarinic agent beta 3 adrenoreceptor agonist mirabegron overactive bladder validated 8-question awareness tool score overactive bladder syndrome solifenacin
Accesso online:	https://journals.lww.com/10.4103/picr.picr_166_23
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!